TOMUDEX subst sèche 2 mg vial
7680535360188
CH-53536
L01BA03
07.16.1.
Reimbursement limitations:
TOMUDEX
Pour le traitement palliatif du cancer colorectal avancé chez les patients donc l'indice de performance …
1 / 3
google
Details
- Product number
- 5353601
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: raltitrexedum 2 mg, dinatrii phosphas dodecahydricus, mannitolum, natrii hydroxidum ad pH, pro vitro corresp. natrium 1.08 mg.
Articles (1)
Tomudex 2 mg, Pulver zur Herstellung einer Infusionslösung
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
1.08 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 206.10
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1999
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 53536
- Drug name
- Tomudex 2 mg, Pulver zur Herstellung einer Infusionslösung
- Galenic form
- PULVI
- ATC Code
- L01BA03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 28/05/1998
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TOMUDEX subst sèche 2 mg vial
- Description (DE)
- TOMUDEX Trockensub 2 mg Vial
- Market launch
- 28/05/1998
- Narcotic (BTM)
- No